Association of the <i>LOX</i> G473A polymorphism with breast cancer risk in the indicated inheritance models and subgroups.

Dominant model, GA+AA vs. GG; recessive model, AA vs. GG+GA; log-additive model, GG = 0, GA = 1, AA = 2; OR, odds ratio; 95% CI, 95% confidence interval; ER, estrogen receptor; PR, progesterone receptor; pN0, no lymph node metastases; pN+, patients with lymph node metastases. apatients aged under 55 years or ≥55 years at diagnosis were compared to control subjects of any age for sake of comparability with the other subgroup analyses.